Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huxley Medical has developed the SANSA platform, an FDA-cleared home-based diagnostic system that uses a wearable patch to simultaneously assess multiple physiological parameters for diagnosing obstructive and central sleep apnea. Recent clinical data presented at SLEEP 2025 demonstrated strong performance in detecting central sleep apnea compared to in-lab polysomnography, as well as the ability to identify previously unrecognized cardiac arrhythmias during home testing. The SANSA device is cleared for use in diagnosing obstructive sleep apnea; its arrhythmia detection capabilities are still under FDA review[1][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huxley Medical.